CCI250117C120000
- 0.05
- 0.000.00%
Crown Castle Newsroom
Analysts' Opinions Are Mixed on These Real Estate Stocks: Crown Castle (CCI) and Healthpeak Properties (DOC)
Barclays Maintains Crown Castle(CCI.US) With Hold Rating, Maintains Target Price $117
BMO Capital Cuts Price Target on Crown Castle to $106 From $115, Keeps Market Perform Rating
Goldman Sachs Adjusts Crown Castle Price Target to $116 From $120, Maintains Neutral Rating
Crown Castle Cut to Underweight From Equal-Weight by Wells Fargo
Crown Castle Analyst Ratings
Wells Fargo Downgrades Crown Castle(CCI.US) to Sell Rating, Maintains Target Price $100
Barclays Downgrades Crown Castle(CCI.US) to Hold Rating, Cuts Target Price to $117
Crown Castle Is Maintained at Equal-Weight by Barclays
Crown Castle Analyst Ratings
Barclays Maintains Crown Castle(CCI.US) With Hold Rating, Raises Target Price to $117
Crown Castle Analyst Ratings
RBC Capital Maintains Crown Castle(CCI.US) With Hold Rating, Raises Target Price to $109
RBC Raises Price Target on Crown Castle to $109 From $104, Keeps Sector Perform Rating
Analysts Offer Insights on Real Estate Companies: First Industrial Realty (FR), Crown Castle (CCI) and Weyerhaeuser (WY)
BMO Capital Maintains Crown Castle(CCI.US) With Hold Rating, Raises Target Price to $115
BofA Securities Maintains Crown Castle(CCI.US) With Hold Rating, Maintains Target Price $115
Crown Castle Price Target Raised to $105.00/Share From $100.00 by Wells Fargo
Crown Castle Is Maintained at Equal-Weight by Wells Fargo
HSBC Adjusts Price Target on Crown Castle to $120 From $110